Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 312,332 | 257,948 | 310,810 | 174,046 | 254,844 |
| Marketable Securities | 682,401 | 746,124 | 854,201 | 989,052 | 1,280,833 |
| TOTAL | $1,042,458 | $1,047,157 | $1,205,740 | $1,213,097 | $1,588,226 |
| Non-Current Assets | |||||
| PPE Net | 63,183 | 64,791 | 66,063 | 92,477 | 96,018 |
| Investments And Advances | 190,015 | 271,495 | 279,992 | 359,724 | 105,275 |
| Intangibles | 25,057 | 36,196 | 35,836 | 39,402 | 39,502 |
| Other Non-Current Assets | 78,100 | 78,717 | 81,924 | 89,269 | 90,039 |
| TOTAL | $356,355 | $451,199 | $463,815 | $580,872 | $330,834 |
| Total Assets | $1,398,813 | $1,498,356 | $1,669,555 | $1,793,969 | $1,919,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,081 | 7,305 | 4,389 | 7,114 | 6,334 |
| Accrued Expenses | 98,521 | 94,658 | 75,321 | 72,260 | 104,220 |
| Other current liabilities | 16,060 | N/A | N/A | N/A | N/A |
| TOTAL | $119,662 | $117,161 | $96,412 | $94,068 | $175,407 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 15,198 | 16,702 | 14,694 | 64,853 |
| Other Non-Current Liabilities | 128,766 | 140,468 | 139,473 | 151,019 | 153,417 |
| TOTAL | $128,766 | $140,468 | $139,473 | $152,545 | $153,417 |
| Total Liabilities | $248,428 | $257,629 | $235,885 | $246,613 | $328,824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 137,143 | 137,720 | 136,640 | 136,059 | 135,032 |
| Common Shares | 14 | 14 | 14 | 14 | 13 |
| Retained earnings | -759,784 | -655,195 | -441,478 | -303,100 | -237,824 |
| Other shareholders' equity | -1,717 | 1,127 | -2,879 | -2,397 | -815 |
| TOTAL | $1,150,385 | $1,240,727 | $1,433,670 | $1,547,356 | $1,590,236 |
| Total Liabilities And Equity | $1,398,813 | $1,498,356 | $1,669,555 | $1,793,969 | $1,919,060 |